Actualités InFlectis BioScience-PR- EMA ODD January 2016 Home > IFB-088 (Sephin1) receives orphan drug designation in the European Union for the treatment of Charcot-Marie-Tooth disease > InFlectis BioScience-PR- EMA ODD January 2016 11 février 2016 InFlectis BioScience-PR- EMA ODD January 2016